Remove Engineering Remove Leads Remove Safety Remove Specialization
article thumbnail

Handling HPAPIs safely – what does it take?

European Pharmaceutical Review

There are emerging trends in oncology, with new chemical entities (NCEs) and antibody-drug conjugates (ADC) leading to increased demand for HPAPI manufacturing capabilities. The compounds require special handling due to their cytotoxicity in the NCEs and investigational new drug applications (INDs).

Safety 89
article thumbnail

Syngene International Ltd.-Walk-In Drive for Multiple Positions in M.Sc/ M.Pharma/ B.Tech/ M.Tech/ B.Sc / Diploma On 11th Dec’ 2022

Pharma Pathway

We officer services in a wide range of industrial sectors, including pharmaceutical, biotechnology, nutrition, animal health, consumer goods and speciality chemical companies. Qualification: M.Sc/ M.Pharma/ B.Tech/ M.Tech/ B.Sc / Diploma in Biotechnology/ Chemistry/ Chemical Engineering. We are hiring! Designation: Executive/ Sr.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Precision Optics Appoints Mahesh Lawande as Chief Operating Officer

Legacy MEDSearch

(NASDAQ: POCI ), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of medical device and aerospace/defense industry manufacturing veteran, Mahesh Lawande, as the Company’s Chief Operating Officer effective April 24, 2023.

article thumbnail

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

Medgadget

The market’s current leading liquid embolic contains a solvent, dimethyl sulfoxide (DMSO), which can cause pain upon injection, necessitating the use of anesthesia and special compatible catheters. Medgadget: Does the material require a specialized delivery device? How is it delivered, and how do you prevent device blockage?

Medical 69
article thumbnail

GAMP 5 update: computerized system expectations for pharma manufacturers

European Pharmaceutical Review

As ISPE GAMP 5 Second Edition notes in the preface “Operating in a highly regulated industry may lead practitioners to apply prescriptive and rigid compliance-based approaches that are not commensurate with and not effective in managing any actual risk to the product and the patient.” Takeaways from ISPE’s GAMP 5 Second Edition update.

article thumbnail

Taking advantage of protein charge properties for challenging separations

European Pharmaceutical Review

The removal/separation of impurities and ensuring the purity of biologics is essential to the safety and quality of the therapeutic. Not only can impurities lead to adverse effects in patients, but they can also introduce product variability.

article thumbnail

The Latest Biotech Trends of 2022

Impetus Digital

Many people believe that this new development will lead to much better treatments, saving time on trial-and-error testing procedures before determining what works best for each patient’s unique health needs. This streamlined process could lead to swifter approvals of effective treatments, which would be a huge win for patients.